Keiichi Fujiwara

Also affiliated with Saitama Medical University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial”.

Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial

Journal of Clinical Oncology(2022)10.1200/jco.21.02011

N/A

2.6DataRank · unranked

88 citations

Mark F. Brady, Ursula A. Matulonis, Austin Miller, Elise C. Kohn, Elizabeth M. Swisher +16 more

A phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6003

N/A

0DataRank · unranked

56 citations

Mark F. Brady, Ursula A. Matulonis, Austin Miller, Elise C. Kohn, Elizabeth M. Swisher +15 more

Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer

Obstetrical & Gynecological Survey(2020)10.1097/ogx.0000000000000777

N/A

0DataRank · unranked

6 citations

Nick M. Spirtos, Danielle Enserro, Thomas J. Herzog, Paul Sabbatini, Deborah K. Armstrong +19 more

Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research

Carcinogenesis(2021)10.1093/carcin/bgab043

N/A

0DataRank · unranked

12 citations

Glauco Baiocchi, David D.L. Bowtell, Citadel J. Cabasag, Kathleen R. Cho, Renée T. Fortner +15 more

Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup

The Lancet Oncology(2022)10.1016/s1470-2045(22)00139-5

N/A

0DataRank · unranked

142 citations

Antonio González-Martı́n, Domenica Lorusso, Charlie Gourley, Mansoor Raza Mirza, Jean‐Emmanuel Kurtz +73 more

Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study

American Journal of Obstetrics and Gynecology(2022)10.1016/j.ajog.2022.06.052

N/A

0DataRank · unranked

61 citations

Tabassum Khan, Juraj Bracinik, James Glasbey, Nadeem Abu-Rustum, Luis Chiva +91 more

Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-0226

N/A

0DataRank · unranked

57 citations

Kirsten B. Burdett, Kouros Owzar, David Tritchler, Alexander B. Sibley, Yingmiao Liu +16 more

Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician’s Choice

European Journal of Cancer(2023)10.1016/j.ejca.2023.03.015

N/A

0DataRank · unranked

17 citations

Nicoletta Colombo, Antonio Casado, Alessandro D. Santin, Émeline Colomba, David S. Miller +14 more